Keywords: tercica, submits, increlex, maa, californian, biopharmaceutical, company

Tercica submits Increlex MAA

Article | 19 December 2005

Californian biopharmaceutical company Tercica says that it has submitted a Marketing Authorization Application to the European MedicinesAgency (EMEA) products for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Mecasermin [rDNA origin] Injection

Increlex

Amino Acids

Somatropin

Humulin R

Go to drug listing